Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.15
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 618,595
  • Market Cap: £2.25m
  • RiskGrade: 435

Latest ShareCast News

Ambrose exercises ValiRx oncology option worth up to £16m

By Josh White

Date: Friday 20 Jun 2025

(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth up to £16m plus royalties.

Valirx ShareCast News

ValiRx terminates exclusive negotiations with Th... 03-Apr-2025 ShareCast
ValiRx's Inaphaea inks deal with UK-based Screen... 03-Feb-2025 ShareCast
ValiRx enters evaluation and option deal with Ca... 29-Jan-2025 ShareCast
ValiRx further extends letter of intent with The... 31-Dec-2024 ShareCast
ValiRx shares tank on £1.6m fundraising plan to ... 09-Dec-2024 ShareCast

Valirx Regulatory News

Ambrose Exercise Option on VAL401 20-Jun-2025 07:00 RNS
ValiRx Investor Webinar 09-Jun-2025 10:57 RNS
Holding(s) in Company 06-Jun-2025 10:54 RNS
Final Results & Notice of AGM 06-Jun-2025 07:00 RNS
New Evaluation and Material Transfer Agreement 03-Jun-2025 07:00 RNS

Valirx Newspaper Links

Business Digest 24-Sep-2006 Sunday Times

Valirx Tips & Analysis

IOS acquires Indian restaurants owner 30-Jan-2008 Times
Small caps 13-Nov-2007 Times
Kelda springs to life as takeover talk bubbles up 11-Sep-2007 Telegraph
Kelda climbs on revived takeover speculation 11-Sep-2007 The Independent
Alliance & Leicester buoyed by talk of NAB bid 09-Aug-2007 The Independent

Valirx News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.15
52 Week Low 0.42
Volume 618,595
Shares Issued 374.35m
Market Cap £2.25m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.38% above the market average35.38% above the market average35.38% above the market average35.38% above the market average35.38% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average73.91% below the sector average
Income Not Available
Growth
24.41% above the market average24.41% above the market average24.41% above the market average24.41% above the market average24.41% above the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

Valirx Dividends

No dividends found

Trades for 24-Jun-2025

Time Volume / Share Price
13:28 240 @ 0.59p
12:59 30,000 @ 0.64p
11:44 150,000 @ 0.59p
10:47 150,000 @ 0.59p
10:15 23,795 @ 0.59p

Valirx Key Personnel

CFO Gerald Desler

Top of Page